In contrast, GM1/2/3 showed weaker effects on the behavioral disorders of PD mice than MA, but GM1/2/3 significantly inhibited the occurrence of apoptosis, increased expression of NGF and its receptors, and enhanced proteins levels of TH and DAT. This evidence concerns the gene NGF and Parkinson disease.